ProKidney Competitors and Similar CompaniesClear all
Mesoblast's competitors and similar companies include ImmusanT and Chinook Therapeutics.
 Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. |  ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. |  Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | |
Founding Date | Founding Date 2004 | Founding Date 2010 | Founding Date 2011 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Cambridge, US HQ | Locations Seattle, US HQ |
Employees | Employees 73 | Employees 2 | Employees 27 |
Financial | |||
Revenue (est.) | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $6.1m (FY, 2022) |
Net income | Net income ($102.1m) (FY, 2025) | Net income N/A | Net income ($187.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 56.2m | Total funding raised $ 72.8m | Total funding raised $ 171m |
For sources of this data, please see the company profile
View Company Profiles
ImmusanT
HQ
Cambridge, US
Employees
2
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View companyChinook Therapeutics
HQ
Seattle, US
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company